Celecoxib, a selective COX-2 inhibitor, shifted the TAM phenotype from M2 to M1 in a colorectal cancer animal model in accordance to the decrease in the number of polyps in ApcMin/1 mice (48). Here, PTGS2 is linked to colorectal cancer.